Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY53.00 CNY
Change Today -1.84 / -3.36%
Volume 5.9M
300255 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

hebei changshan biochemica-a (300255) Snapshot

Open
CNY54.60
Previous Close
CNY54.84
Day High
CNY55.89
Day Low
CNY52.85
52 Week High
04/14/15 - CNY65.16
52 Week Low
04/28/14 - CNY22.30
Market Cap
10.0B
Average Volume 10 Days
6.4M
EPS TTM
CNY0.71
Shares Outstanding
188.4M
EX-Date
04/30/15
P/E TM
74.6x
Dividend
CNY0.09
Dividend Yield
--
Current Stock Chart for HEBEI CHANGSHAN BIOCHEMICA-A (300255)

Related News

No related news articles were found.

hebei changshan biochemica-a (300255) Related Businessweek News

No Related Businessweek News Found

hebei changshan biochemica-a (300255) Details

Hebei Changshan Biochemical Pharmaceutical Co. Ltd. researches, develops, produces, and sells heparin products. Its principal products include heparin sodium API, LMW heparin calcium injections, heparin sodium injections, sodium hyaluronate, and hard capsules, as well as Yihaitang capsule, an anti-aging health product. The company sells its products in approximately 30 countries and districts worldwide. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. was founded in 2000 and is based in Zhengding, China.

Founded in 2000

hebei changshan biochemica-a (300255) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hebei changshan biochemica-a (300255) Key Developments

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Announces 2014 Final Distribution Plan, Payable on April 30, 2015

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. proposed cash dividend (A shares) for the year of 2014. The company announced cash dividend of CNY 0.85000 per 10 shares (tax included) payable on April 30, 2015 with record date as on April 29, 2015 and ex-date as on April 30, 2015. Tax on cash dividend per 10 shares of CNY 0.085000. Net cash dividend per 10 shares after tax of CNY 0.765000.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. to Report Q1, 2015 Results on Apr 25, 2015

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced that they will report Q1, 2015 results on Apr 25, 2015

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Approves Amendments to the Articles of Association

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced that at the annual general meeting held on April 15, 2015 it approved increase in the registered capital of the company and amendments to the articles of association of the company and handling the changes in the industrial and commercial registration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300255:CH CNY53.00 CNY -1.84

300255 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300255.
View Industry Companies
 

Industry Analysis

300255

Industry Average

Valuation 300255 Industry Range
Price/Earnings 74.8x
Price/Sales 12.8x
Price/Book 7.3x
Price/Cash Flow 74.8x
TEV/Sales 11.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEBEI CHANGSHAN BIOCHEMICA-A, please visit www.heparin.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.